We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+3.98%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.1B
AUM Growth
+$134M
(+0.89%)
Cap. Flow
-$3.91B
Cap. Flow
% of AUM
-25.89%
Top 10 Holdings %
Top 10 Hldgs %
18.53%
Holding
722
New
62
Increased
243
Reduced
170
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MetLife
MET
|
+$92.3M |
| 2 |
Microsoft
MSFT
|
+$73.7M |
| 3 |
ExxonMobil
XOM
|
+$73.7M |
| 4 |
Starbucks
SBUX
|
+$72.3M |
| 5 |
Procter & Gamble
PG
|
+$54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MLU
METLIFE, INC. COM EQUITY UNIT
MLU
|
+$130M |
| 2 |
SLB Ltd
SLB
|
+$108M |
| 3 |
UTX.PRA
UNITED TECHNOLOGIES CORP CORP UNIT (DE)
UTX.PRA
|
+$82M |
| 4 |
Eaton
ETN
|
+$72.7M |
| 5 |
CELG
Celgene Corp
CELG
|
+$57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.08% |
| 2 | Technology | 11.12% |
| 3 | Healthcare | 9.42% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Agilent Technologies
A
$39.1B
| $14.7M | 0.1% |
357,946
-17,260
| -5% | -$696K |
|
152
Lamar Advertising Co
LAMR
$16.2B
| $14.5M | 0.1% |
270,618
-9,282
| -3% | -$479K |
|
153
Cisco
CSCO
$450B
| $14.3M | 0.09% |
514,471
+2,671
| +0.5% | +$69K |
|
154
Honeywell
HON
$77.1B
| $14.1M | 0.09% |
157,163
+579
| +0.4% | +$49.8K |
|
|
FRC
155
DELISTED
First Republic Bank
FRC
| $14M | 0.09% |
268,500
-311,825
| -54% | -$15.7M |
|
156
Protolabs
PRLB
$1.86B
| $13.9M | 0.09% |
206,259
-847
| -0.4% | -$55.7K |
|
157
Altria Group
MO
$122B
| $13.7M | 0.09% |
278,345
+1,445
| +0.5% | +$70.4K |
|
158
Lowe's Companies
LOW
$116B
| $13.4M | 0.09% |
194,912
+1,012
| +0.5% | +$60.6K |
|
|
INXN
159
DELISTED
Interxion Holding N.V.
INXN
| $13.2M | 0.09% |
484,105
+440,040
| +999% | +$11.9M |
|
160
Masco
MAS
$16B
| $13.1M | 0.09% |
592,175
+415
| +0.1% | +$8.57K |
|
|
DFS
161
DELISTED
Discover Financial Services
DFS
| $12.6M | 0.08% |
191,766
+266
| +0.1% | +$17.1K |
|
|
PPLI
162
People Inc
PPLI
$3.1B
| $11.9M | 0.08% |
+1,091,222
| New | +$12.4M |
|
163
ConocoPhillips
COP
$147B
| $11.4M | 0.08% |
164,547
+647
| +0.4% | +$45.2K |
|
164
Duke Energy
DUK
$102B
| $11.3M | 0.07% |
135,403
+703
| +0.5% | +$56.7K |
|
|
MON
165
DELISTED
Monsanto Co
MON
| $11.3M | 0.07% |
94,189
+489
| +0.5% | +$56.8K |
|
|
SNDK
166
DELISTED
SANDISK CORP
SNDK
| $11M | 0.07% |
+112,706
| New | +$10.8M |
|
|
BNY
167
Bank of New York Mellon
BNY
$108B
| $10.5M | 0.07% |
257,625
+1,125
| +0.4% | +$44K |
|
168
Brunswick
BC
$5.19B
| $10.3M | 0.07% |
201,215
-107,528
| -35% | -$5.03M |
|
169
Thermo Fisher Scientific
TMO
$211B
| $10.2M | 0.07% |
81,222
+422
| +0.5% | +$51.3K |
|
170
Carnival Corporation Ltd
CCL
$36.1B
| $10.2M | 0.07% |
224,115
| – | – |
|
171
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
| $10M | 0.07% |
+37,919
| New | +$9.71M |
|
172
Bristol-Myers Squibb
BMY
$127B
| $9.7M | 0.06% |
164,269
+13,169
| +9% | +$743K |
|
173
General Dynamics
GD
$105B
| $9.68M | 0.06% |
70,365
+365
| +0.5% | +$49.7K |
|
174
Rio Tinto
RIO
$148B
| $9.67M | 0.06% |
210,000
| – | – |
|
175
Navient
NAVI
$774M
| $9.51M | 0.06% |
439,903
-278,189
| -39% | -$5.56M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Calamos Advisors held 722 positions worth $15.1B, up 0.89% from $15B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Calamos Advisors withdrew a net $3.91B in Q4 2014, closing 71 positions and reducing 170 holdings. Its most notable exit was METLIFE, INC. COM EQUITY UNIT, an estimated $130M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Northrop Grumman worth $29.4M.
- Calamos Advisors's largest Q4 2014 buy was Northrop Grumman: 199,438 shares worth $29.4M.
- Calamos Advisors added most to MetLife in Q4 2014, an estimated $92.3M increase.
- Calamos Advisors's biggest Q4 2014 reduction was SLB Ltd, cutting an estimated $108M.
- Calamos Advisors fully exited METLIFE, INC. COM EQUITY UNIT in Q4 2014, selling an estimated $130M.
- Calamos Advisors's ten largest holdings make up 19% of its $15.1B portfolio in Q4 2014.
- Calamos Advisors opened 62 new positions and closed 71 in Q4 2014.
- Calamos Advisors's portfolio value rose 0.89% quarter-over-quarter to $15.1B.
Based on Calamos Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.